Cardlytics grants 50,000 RSUs to legal chief

Cheng Christopher Chi-Kit reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Cheng Christopher Chi-Kit reported acquisition or exercise transactions in this Form 4 filing.

Cardlytics, Inc. granted 50,000 Restricted Stock Units (RSUs) to Chief Legal & Privacy Officer Christopher Chi-Kit Cheng. Each RSU represents a contingent right to receive one share of Common Stock. The award vests over 24 months, with 25,000 units vesting on September 1, 2027 and the remainder vesting quarterly over the following 12 months, subject to continued employment. Following this grant, Cheng holds 50,000 RSUs directly.

Insider Trade Summary

Grant/Award: 50,000 shares

Grant/Award 1 txn

Insider Cheng Christopher Chi-Kit

Role Chief Legal & Privacy Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units F1, F2	50,000	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 50,000 contracts (Direct)

Footnotes (2)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
2. F2. The restricted stock units shall vest over a period of 24 months, with 25,000 shares vesting on September 1, 2027 and the remaining shares vesting quarterly over the subsequent 12 months, provided that the Reporting Person remains employed by the Issuer on such vesting dates.

Key Figures

RSUs granted: 50,000 units Underlying common shares: 50,000 shares Initial vesting tranche: 25,000 units +3 more

6 metrics

RSUs granted 50,000 units Restricted Stock Units granted on 2026-08-03 to the Chief Legal & Privacy Officer

Underlying common shares 50,000 shares Each RSU represents a contingent right to receive one share of Common Stock

Initial vesting tranche 25,000 units First portion of RSUs vesting on September 1, 2027, subject to continued employment

Vesting period 24 months RSUs vest over 24 months with remaining units vesting quarterly after initial tranche

RSUs held after transaction 50,000 units Total Restricted Stock Units directly held by the reporting person following the grant

Transaction price per RSU $0.0000 per unit Grant of RSUs with no purchase price paid by the reporting person

Key Terms

Restricted Stock Units, contingent right, vest, Reporting Person

4 terms

Restricted Stock Units financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share"

vest financial

"The restricted stock units shall vest over a period of 24 months, with 25,000 shares vesting"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

Reporting Person financial

"provided that the Reporting Person remains employed by the Issuer on such vesting dates"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Cardlytics (CDLX) report for Christopher Chi-Kit Cheng?

Cardlytics granted 50,000 Restricted Stock Units (RSUs) to Chief Legal & Privacy Officer Christopher Chi-Kit Cheng. Each RSU is a right to receive one share of Common Stock, subject to the award’s vesting schedule and continued employment conditions.

How many RSUs were granted in this Cardlytics (CDLX) Form 4 filing?

The filing reports a grant of 50,000 Restricted Stock Units to the Chief Legal & Privacy Officer. These RSUs correspond to 50,000 shares of Cardlytics Common Stock if and when they vest and settle, assuming all vesting conditions are met.

What is the vesting schedule for the 50,000 RSUs at Cardlytics (CDLX)?

The 50,000 RSUs vest over 24 months. 25,000 units vest on September 1, 2027, and the remaining RSUs vest quarterly over the subsequent 12 months, contingent on the reporting person remaining employed by Cardlytics on each vesting date.

What does each RSU represent in the Cardlytics (CDLX) award to Christopher Cheng?

Each Restricted Stock Unit represents a contingent right to receive one share of Cardlytics Common Stock. The units convert into shares only as they vest and settle in accordance with the specified vesting schedule and employment-based conditions.

What is Christopher Cheng’s Cardlytics (CDLX) equity position after this RSU grant?

After the reported transaction, Christopher Chi-Kit Cheng directly holds 50,000 Restricted Stock Units. These RSUs may convert into an equal number of Cardlytics Common Stock shares if the vesting conditions are satisfied over the 24‑month vesting period.

On what date was the RSU grant to the Cardlytics (CDLX) officer made?

The grant of 50,000 Restricted Stock Units to the Chief Legal & Privacy Officer is dated 2026-08-03. Vesting begins later, with the first tranche scheduled to vest on September 1, 2027, subject to continued employment at Cardlytics.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/04/2026 - 07:02 PM Accepted by SEC EDGAR 08/04/2026 - 07:01 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cheng Christopher Chi-Kit

(Last) (First) (Middle)

675 PONCE DE LEON AVENUE NE

SUITE 4100

(Street)

ATLANTA GEORGIA 30308

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cardlytics, Inc. [ CDLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal & Privacy Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	08/03/2026		A		50,000		(2)	(2)	Common Stock	50,000	$0	50,000	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

2. The restricted stock units shall vest over a period of 24 months, with 25,000 shares vesting on September 1, 2027 and the remaining shares vesting quarterly over the subsequent 12 months, provided that the Reporting Person remains employed by the Issuer on such vesting dates.

Remarks:

	/s/ Chris Cheng	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)